Preferred Label : tumor necrosis factor alpha;

Details


Main resources

You can consult :


https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-utilisation-biosimilaires-anti-tnf-alpha
2022
France
Biosimilars
anti-TNF
France
France
France
biosimilar pharmaceuticals
tumor necrosis factor alpha
france
french
France
tumor necrosis factor-alpha

---
http://www.sudoc.fr/232421579
2018
false
false
false
France
dissertations, academic
patients
Vaccination Coverage
tumor necrosis factor-alpha
cohort studies
has patient
tumor necrosis factor alpha
therapeutics
anti-TNF
preventive immunization/medication

---
https://pharmacomedicale.org/medicaments/par-specialites/item/anti-tnf-alpha
2015
false
false
false
France
French
drug information
tumor necrosis factor-alpha
Tumor necrosis factor alpha (TNF-α) inhibitors
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
tumor necrosis factor-alpha
tumor necrosis factor alpha
Tumor Necrosis Factor Inhibitors

---
https://dumas.ccsd.cnrs.fr/dumas-01253135
2015
false
false
false
France
French
dissertations, academic
uveitis
tumor necrosis factor alpha
Treatment Efficacy
has patient
patients
tumor necrosis factor-alpha
retrospective studies
therapeutics
panuveitis
effective
treatment outcome

---
http://www.sudoc.fr/192195689
2015
false
false
false
France
French
dissertations, academic
tumor necrosis factor-alpha
risk
occupational
review literature
occupational exposure
tumor necrosis factor alpha
review
anti-infective agents
effects of exposure to external cause, nos
review literature as topic
proband
review

---
Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.